Swasth Foodtech India IPO: Check key dates, GMP, price band and other details
Swasth Foodtech India plans to raise Rs 15 crore through its SME IPO opening on February 20. The company will offer 15.87 lakh shares at Rs 94 each without any OFS component. Swasth processes and sells edible rice bran oil, which is rich in Vitamin E and Oryzanol.
Stocks to buy: Zen Technologies, Tata Motors and Data Patterns on investors’ radar
Benchmark indices Sensex and Nifty close slightly lower amid volatile trading, with blue-chip IT stocks taking a hit. Zen Technologies rose by 10%, Tata Motors saw a minor decline of 0.2%, and Data Patterns gained 9%. Experts suggest cautious trading strategies for these stocks.
India’s appeal is for the long term: FTSE Russell CEO
FTSE Russell said in October it would include India’s sovereign bonds in its Emerging Markets Government Bond Index from September 2025. JP Morgan and Bloomberg Index Services have also announced the inclusion of the country’s bonds in their indices, a move that will result in a flood of money into these securities.
Asian stocks drop after Fed Minutes show caution
Stocks in Japan and Australia dropped while equity index futures for Hong Kong also drifted lower. Contracts for US stocks also slipped in early Asian trading after the S&P 500 climbed 0.2% on Wednesday to set a new high, with defensive sectors outperforming in a sign of investor caution.
HSBC India’s pre-tax profit up 11% in 2024
HSBC, Europe’s largest lender by assets, reported an 11% increase in pre-tax profit in its Indian operations to $1.68 billion for the last calendar year, driven by growth in both wholesale and retail banking. The bank, recently approved to expand in India, aims to leverage new local opportunities.
Fino Payments doubles down on loans, SFB aim in focus
Being a payments bank, Mumbai-based Fino cannot offer credit from its own balance sheet. It needs to work with other lenders as a sourcing partner. The bank is currently undertaking pilots around products such as home loans, gold loans and other micro-credit products for merchants.
Macquarie bullish on Suven Pharma, Divi’s Labs, Bluejet and Syngene
Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressures and geopolitical factors, prompting a global restructuring of the pharmaceutical supply chain.
Hexaware Tech lists at 5% above IPO price
After delisting from the Indian bourses in November 2020, the software services company returned to the capital market by selling shares worth ₹8,750 crore in the IPO last week, making it the largest Indian IT services IPO exceeding Tata Consultancy Services’ ₹4,713 crore public issue in 2004.
Replicating Blinkit’s Q-Comm moves won’t ensure success: Albinder Dhindsa
These expansion costs are unavoidable, whether incurred through marketing or idle expenses. Most of our current burn is due to expansion. Based on our growth trends, we could have covered our expansion costs.
Trump says unfair to US if Musk builds factory in India
Tesla’s CEO Elon Musk has long criticised India for having import tariffs of around 100% on EVs which protect local automakers such as Tata Motors in the world’s third largest auto market, where EV adoption is still at a nascent stage.